Efficacy News and Research

RSS
New evidence that positive framing could improve COVID vaccine uptake globally

New evidence that positive framing could improve COVID vaccine uptake globally

UK's world-leading human challenge study provides new insights into mild SARS-CoV-2 infections

UK's world-leading human challenge study provides new insights into mild SARS-CoV-2 infections

CECR2 gene inhibition prevents triple-negative breast cancer from metastasizing, study shows

CECR2 gene inhibition prevents triple-negative breast cancer from metastasizing, study shows

Exploring protection via a 4th dose of BNT162b2 against SARS-CoV-2 Omicron variant in Israel

Exploring protection via a 4th dose of BNT162b2 against SARS-CoV-2 Omicron variant in Israel

The ability of individuals to cross-recognize the Omicron spike protein following vaccination or prior infection

The ability of individuals to cross-recognize the Omicron spike protein following vaccination or prior infection

Quantitative framework to investigate the dynamic mechanism of host immune response confronting SARS-CoV-2 infection

Quantitative framework to investigate the dynamic mechanism of host immune response confronting SARS-CoV-2 infection

Novel approach to improve intranasal sprays used to treat respiratory viral infections

Novel approach to improve intranasal sprays used to treat respiratory viral infections

New nanoparticle SARS-CoV-2 vaccine shows stronger, broader, and more durable protection

New nanoparticle SARS-CoV-2 vaccine shows stronger, broader, and more durable protection

COVID-19 vaccines induce robust cellular immune response against SARS-CoV-2 Omicron

COVID-19 vaccines induce robust cellular immune response against SARS-CoV-2 Omicron

Study finds that high-dose convalescent plasma does not improve outcomes for severe COVID-19

Study finds that high-dose convalescent plasma does not improve outcomes for severe COVID-19

High levels of neutralizing antibodies against Omicron after BNT162b2 booster vaccination

High levels of neutralizing antibodies against Omicron after BNT162b2 booster vaccination

C-Path and EJP RD collaborate to expand global rare disease research and drug development

C-Path and EJP RD collaborate to expand global rare disease research and drug development

Neural stem cells plus HER2 inhibitor drug improve survival in mice with metastatic cancer

Neural stem cells plus HER2 inhibitor drug improve survival in mice with metastatic cancer

Assessing the effects of booster vaccinations against SARS-CoV-2 Omicron variant

Assessing the effects of booster vaccinations against SARS-CoV-2 Omicron variant

Assessing the neutralizing ability of polyclonal antibody XAV-19 against SARS-CoV-2 Omicron variant

Assessing the neutralizing ability of polyclonal antibody XAV-19 against SARS-CoV-2 Omicron variant

Study shows mRNA booster dose eliminates immune escape observed with SARS-CoV-2 Omicron

Study shows mRNA booster dose eliminates immune escape observed with SARS-CoV-2 Omicron

Study highlights importance of immunizing and boosting PAD syndromes patients with SARS-CoV-2 mRNA vaccines

Study highlights importance of immunizing and boosting PAD syndromes patients with SARS-CoV-2 mRNA vaccines

Combined strategy suppresses the growth of deadly brain tumor

Combined strategy suppresses the growth of deadly brain tumor

Yellow fever vaccine-vectored YF-S0 as a potent COVID-19 vaccine candidate

Yellow fever vaccine-vectored YF-S0 as a potent COVID-19 vaccine candidate

Researchers assess outcomes of a self-care program for women with pelvic organ prolapse

Researchers assess outcomes of a self-care program for women with pelvic organ prolapse

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.